Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
Alexandria Forbes
|
| gptkbp:collaboratesWith |
gptkb:Janssen_Pharmaceuticals
|
| gptkbp:countryOfOrigin |
gptkb:United_Kingdom
gptkb:United_States |
| gptkbp:developedBy |
AAV-based gene therapies
|
| gptkbp:focusesOn |
neurology
ophthalmology gene therapy salivary gland disorders |
| gptkbp:foundedYear |
2015
|
| gptkbp:headquartersLocation |
gptkb:London,_United_Kingdom
gptkb:New_York,_United_States |
| https://www.w3.org/2000/01/rdf-schema#label |
MeiraGTx
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:publiclyTraded |
true
|
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
MGTX
|
| gptkbp:website |
https://meiragtx.com/
|
| gptkbp:bfsParent |
gptkb:UCL_Technology_Fund
|
| gptkbp:bfsLayer |
8
|